To study the effect of Ayurvedic formulations on PramehajanyaTimira/Diabetic Macular Edema.

Phase 2

Completed

• Conditions: Health Condition 1: E133- Other specified diabetes mellituswith ophthalmic complications

• Registration Number: CTRI/2022/06/043269
• Lead Sponsor: ational Institute of Ayurveda

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2023-07-31
• Last Update Posted: 13 November 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

1.Patients between 40-70 years of age.

2.Diagnosed cases of Diabetes Mellitus Type 2.

3.NPDR cases with Macular Edema.

4.Clinically significant Diabetic Macular

Edema of less than 12 months duration.

5.Visual acuity minimum 6/60 or better.

6.Patients having HbA1c levels upto 8.

Exclusion Criteria

1.Hypertensive patients with systolic BP >160

and diastolic BP >95 mm Hg.

2.Patients having HbA1c levels greater than

8.

3.Diabetic patients with cardiovascular

problems.

4.History of ocular surgery within 4 months

prior to enrolment.

5.Pregnant diabetic patients.

6.Patients with moderate to severe

cataractous changes.

7.Patients having a history of glaucoma or

on-going treatment of glaucoma.

Study & Design

• Study Type: Interventional
• Study Design: Not specified